Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale President & CEO sold 87,500 shares at $12.35 ($1,080,625)
  2. 4 Grant or award SVP & Chief Accounting Officer acquired 15,000 shares (grant or award)
  3. 4 Grant or award President & CEO acquired 55,000 shares (grant or award)
  4. 4 Grant or award SVP & Chief Operating Officer acquired 20,000 shares (grant or award)
  5. 4 Grant or award SVP & Chief Financial Officer acquired 20,000 shares (grant or award)
  6. 4 Grant or award SVP Pharma Dev & Mfg Ops acquired 15,000 shares (grant or award)
  7. 4 Grant or award SVP & Chief Medical Officer acquired 20,000 shares (grant or award)
  8. 4 Grant or award SVP & Chief Scientific Officer acquired 17,500 shares (grant or award)
  9. 4 Open-market sale President & CEO sold 87,500 shares at $12.24 ($1,071,000)
  10. 4 Open-market sale SVP & Chief Accounting Officer sold 1,986 shares at $13.96 ($27,725)
  11. 4 Open-market sale President & CEO sold 93,458 shares at an average $13.88 ($1,296,799)
  12. 4 Open-market sale SVP & Chief Operating Officer sold 1,654 shares at $13.96 ($23,090)
  13. 4 Open-market sale SVP & Chief Financial Officer sold 1,654 shares at $13.96 ($23,090)
  14. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 1,654 shares at $13.96 ($23,090)
  15. 4 Open-market sale SVP & Chief Medical Officer sold 848 shares at $13.96 ($11,838)
  16. 4 Open-market sale SVP & Chief Scientific Officer sold 670 shares at $13.96 ($9,353)
  17. 4 Open-market buy Director bought 15,000 shares at $13.50 ($202,500)
  18. 4 Open-market sale President & CEO sold 87,500 shares at $17.06 ($1,492,750)
  19. 4 Exercise or conversion Director acquired 46,000 shares (option exercise)
  20. 4 Grant or award Director acquired 8,000 shares (grant or award)

Page 23 of 49 · 970 filings